BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32630655)

  • 1. Collagen Extract Derived from Yeonsan Ogye Chicken Increases Bone Microarchitecture by Suppressing the RANKL/OPG Ratio via the JNK Signaling Pathway.
    N'deh KPU; Yoo HS; Chung KH; Lee KJ; Kim DH; Yoon JA; An JH
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium Supplement Derived from Gallus gallus domesticus Promotes BMP-2/RUNX2/SMAD5 and Suppresses TRAP/RANK Expression through MAPK Signaling Activation.
    Yoo HS; Kim GJ; Song DH; Chung KH; Lee KJ; Kim DH; An JH
    Nutrients; 2017 May; 9(5):. PubMed ID: 28513557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L; Sapkota M; Gao M; Choi H; Soh Y
    Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.
    Khedgikar V; Kushwaha P; Gautam J; Verma A; Changkija B; Kumar A; Sharma S; Nagar GK; Singh D; Trivedi PK; Sangwan NS; Mishra PR; Trivedi R
    Cell Death Dis; 2013 Aug; 4(8):e778. PubMed ID: 23969857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
    Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
    J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanin extract from
    Yoo HS; Chung KH; Lee KJ; Kim DH; An JH
    Nutr Res Pract; 2017 Jun; 11(3):190-197. PubMed ID: 28584575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.
    Liu C; Wang L; Zhu R; Liu H; Ma R; Chen B; Li L; Guo Y; Jia Q; Shi S; Zhao D; Mo F; Zhao B; Niu J; Fu M; Orekhov AN; Brömme D; Gao S; Zhang D
    Osteoporos Int; 2019 Feb; 30(2):491-505. PubMed ID: 30151623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C Activates Osteoblastogenesis and Inhibits Osteoclastogenesis via Wnt/β-Catenin/ATF4 Signaling Pathways.
    Choi HK; Kim GJ; Yoo HS; Song DH; Chung KH; Lee KJ; Koo YT; An JH
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
    Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
    Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells.
    Qian H; Zhao Y; Peng Y; Han C; Li S; Huo N; Ding Y; Duan Y; Xiong L; Sang H
    J Periodontal Res; 2010 Aug; 45(4):504-11. PubMed ID: 20412420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis.
    Wang K; Kou Y; Rong X; Wei L; Li J; Liu H; Li M; Song H
    Drug Des Devel Ther; 2024; 18():1515-1528. PubMed ID: 38716369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.
    El Kholy K; Freire M; Chen T; Van Dyke TE
    Front Immunol; 2018; 9():1300. PubMed ID: 29946319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis.
    Tao X; Qi Y; Xu L; Yin L; Han X; Xu Y; Wang C; Sun H; Peng J
    Pharmacol Res; 2016 Jun; 108():90-101. PubMed ID: 27155058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.